Correlation between percent GATA2+ blasts and clinicopathologic metrics in adult AML cases
| Variable . | P value, test used . |
|---|---|
| Diagnosis | .902J, .827K |
| Def cytogenetic Abn | |
| MRC | |
| NOS | |
| TR | |
| Age at diagnosis, y | .534, S |
| Sex | .635, W |
| Marrow cellularity∗ | .644, S |
| Cytopenia | |
| RBCs | Insufficient data |
| Neutrophils | .002, W |
| Platelets | .125, W |
| Blasts (%) | .955, S |
| Abnormal cytogenetics† | .801, W |
| Complex cytogenetics | .032, W |
| Number of P/LP mutations | .410, J |
| 0-1 | |
| 2-3 | |
| 4-6 | |
| FLT3 mutation | .441, W |
| Variable . | P value, test used . |
|---|---|
| Diagnosis | .902J, .827K |
| Def cytogenetic Abn | |
| MRC | |
| NOS | |
| TR | |
| Age at diagnosis, y | .534, S |
| Sex | .635, W |
| Marrow cellularity∗ | .644, S |
| Cytopenia | |
| RBCs | Insufficient data |
| Neutrophils | .002, W |
| Platelets | .125, W |
| Blasts (%) | .955, S |
| Abnormal cytogenetics† | .801, W |
| Complex cytogenetics | .032, W |
| Number of P/LP mutations | .410, J |
| 0-1 | |
| 2-3 | |
| 4-6 | |
| FLT3 mutation | .441, W |
Significance indicated in bold. Def cytogenetic Abn, defined cytogenetic abnormality; MRC, myelodysplasia-related changes; NOS, not otherwise specified; TR, therapy related; P/LP, pathogenic/likely pathogenic.
Statistical tests: J, Jonckheere; W, Wilcoxon rank-sum; S, Spearman correlation; K, Kruskal-Walls.
n = 74.
n = 72.